Is glucose-induced hypersecretion of glicentin after the revision surgery using Roux-en-Y gastric bypass related to improved glycemic control due to insulin hypersecretion in a type 2 diabetes patient without diabetes remission after laparoscopic sleeve gastrectomy?

MLA

Yamamoto, Yukako, et al. “Is Glucose-Induced Hypersecretion of Glicentin after the Revision Surgery Using Roux-En-Y Gastric Bypass Related to Improved Glycemic Control Due to Insulin Hypersecretion in a Type 2 Diabetes Patient without Diabetes Remission after Laparoscopic Sleeve Gastrectomy?” Journal of Diabetes Investigation, Nov. 2024. EBSCOhost, https://doi.org/10.1111/jdi.14325.

APA

Yamamoto, Y., Sekine, O., Ito-Kobayashi, J., Nishida, A., Togawa, T., Ozamoto, Y., Oe, Y., Hagiwara, A., Kobayashi, M., Kitamura, T., Iwanishi, M., Shimatsu, A., & Kashiwagi, A. (2024). Is glucose-induced hypersecretion of glicentin after the revision surgery using Roux-en-Y gastric bypass related to improved glycemic control due to insulin hypersecretion in a type 2 diabetes patient without diabetes remission after laparoscopic sleeve gastrectomy? Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.14325

Chicago

Yamamoto, Yukako, Osamu Sekine, Jun Ito-Kobayashi, Ayane Nishida, Takeshi Togawa, Yuki Ozamoto, Yasumitsu Oe, et al. 2024. “Is Glucose-Induced Hypersecretion of Glicentin after the Revision Surgery Using Roux-En-Y Gastric Bypass Related to Improved Glycemic Control Due to Insulin Hypersecretion in a Type 2 Diabetes Patient without Diabetes Remission after Laparoscopic Sleeve Gastrectomy?” Journal of Diabetes Investigation, November. doi:10.1111/jdi.14325.